Washington Trust’s Biogen BIIB Stock Holding History

Washington Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-312	Closed	-$47.7K	–	772
2024 Q4	$47.7K	Hold	312	–	–	﹤0.01%	446
2024 Q3	$60.5K	Hold	312	–	–	﹤0.01%	430
2024 Q2	$72.3K	Hold	312	–	–	﹤0.01%	391
2024 Q1	$67.3K	Hold	312	–	–	﹤0.01%	412
2023 Q4	$80.7K	Hold	312	–	–	﹤0.01%	361
2023 Q3	$80.2K	Hold	312	–	–	﹤0.01%	334
2023 Q2	$88.9K	Hold	312	–	–	﹤0.01%	336
2023 Q1	$86.7K	Hold	312	–	–	﹤0.01%	335
2022 Q4	$86.4K	Hold	312	–	–	﹤0.01%	330
2022 Q3	$83K	Hold	312	–	–	﹤0.01%	321
2022 Q2	$64K	Hold	312	–	–	﹤0.01%	364
2022 Q1	$66K	Sell	312 -15	-5%	-$3.26K	﹤0.01%	381
2021 Q4	$78K	Sell	327 -102	-24%	-$26.2K	﹤0.01%	368
2021 Q3	$121K	Buy	429 +2	+0.5%	+$656	﹤0.01%	377
2021 Q2	$148K	Buy	427 +297	+228%	+$90K	﹤0.01%	352
2021 Q1	$36K	Buy	130 +20	+18%	+$5.39K	﹤0.01%	572
2020 Q4	$27K	Buy	110 +60	+120%	+$15.5K	﹤0.01%	616
2020 Q3	$14K	Buy	50 +35	+233%	+$9.76K	﹤0.01%	670
2020 Q2	$4K	Sell	15 -15	-50%	-$4.51K	﹤0.01%	718
2020 Q1	$10K	Buy	+30	New	+$9.1K	﹤0.01%	661
2018 Q3	–	Sell	-255	Closed	-$74K	–	290
2018 Q2	$74K	Buy	+255	New	+$71.7K	﹤0.01%	356

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Washington Trust's BIIB Position: Q1 2025 in Review

Washington Trust sold out of Biogen (BIIB) in Q1 2025, closing a stake of 312 shares — an estimated $47.7K sold.

Washington Trust first reported a position in BIIB in Q2 2018 and held it in 21 quarters. The position peaked at $148K in Q2 2021. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Washington Trust reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
Washington Trust sold 312 Biogen shares in Q1 2025, an estimated $47.7K.
Washington Trust first reported a position in Biogen in Q2 2018 and held it in 21 quarters.
Washington Trust's Biogen position peaked at $148K in Q2 2021.
883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.